Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tumor Lysate-pulsed DC Vaccine in High-risk Solid Tumors
NCT00405327Phase 2Completed
- Sponsor
- University of Michigan Rogel Cancer Center
- Start
- Jun 2006
- Primary completion
- Jun 2009
- Modality
- Whole Cell Cancer Vaccines, Dendritic Cell Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of autologous tumor lysate-pulsed dendritic cells in sarcoma, neuroblastoma, Wilms' tumor, sponsored by University of Michigan Rogel Cancer Center. Started Jun 2006; status: completed.
02
Drugs
autologous tumor lysate-pulsed dendritic cells
03
Conditions
sarcomaneuroblastomaWilms' tumor
Beyond the preview
Go deeper on NCT00405327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405327.